Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.79 Insider Own0.10% Shs Outstand159.28M Perf Week0.24%
Market Cap3.45B Forward P/E- EPS next Y-1.24 Insider Trans-46.98% Shs Float158.33M Perf Month-29.04%
Income-281.60M PEG- EPS next Q-0.54 Inst Own95.00% Short Float4.43% Perf Quarter-60.28%
Sales441.80M P/S7.82 EPS this Y-12.00% Inst Trans-1.23% Short Ratio3.00 Perf Half Y-50.65%
Book/sh3.94 P/B5.40 EPS next Y33.20% ROA-36.50% Target Price29.44 Perf Year-52.64%
Cash/sh3.89 P/C5.47 EPS next 5Y25.00% ROE-43.60% 52W Range20.12 - 58.72 Perf YTD-60.19%
Dividend- P/FCF- EPS past 5Y-1.80% ROI-45.80% 52W High-63.76% Beta0.79
Dividend %- Quick Ratio6.70 Sales past 5Y491.50% Gross Margin95.30% 52W Low5.77% ATR2.03
Employees601 Current Ratio6.80 Sales Q/Q23.10% Oper. Margin-64.90% RSI (14)28.45 Volatility3.78% 4.68%
OptionableYes Debt/Eq0.00 EPS Q/Q-22.20% Profit Margin-63.70% Rel Volume1.21 Prev Close20.60
ShortableYes LT Debt/Eq0.00 EarningsFeb 24 AMC Payout- Avg Volume2.34M Price21.28
Recom2.50 SMA20-12.67% SMA50-42.69% SMA200-52.40% Volume2,816,810 Change3.30%
Apr-07-21Downgrade H.C. Wainwright Buy → Neutral $43 → $18
Apr-06-21Downgrade Mizuho Buy → Neutral $37 → $25
Apr-06-21Downgrade Jefferies Buy → Hold $40 → $21
Apr-06-21Downgrade Goldman Buy → Neutral $73 → $25
Apr-06-21Downgrade Canaccord Genuity Buy → Hold $40 → $26
Apr-05-21Downgrade Raymond James Outperform → Mkt Perform
Mar-10-21Downgrade BofA Securities Buy → Neutral
Mar-09-21Reiterated H.C. Wainwright Buy $60 → $43
Mar-09-21Downgrade Stifel Buy → Hold $68 → $27
Mar-09-21Downgrade Raymond James Strong Buy → Outperform $65 → $35
Mar-09-21Downgrade Guggenheim Buy → Neutral
Mar-09-21Downgrade Citigroup Buy → Neutral $66 → $35
Dec-16-20Initiated Mizuho Buy $69
Nov-16-20Upgrade Raymond James Outperform → Strong Buy $65
Aug-25-20Initiated Raymond James Outperform $65
Aug-20-20Initiated Morgan Stanley Overweight $55
Jul-07-20Upgrade Stifel Hold → Buy $41 → $71
Apr-16-20Initiated Jefferies Buy $60
Mar-31-20Upgrade Goldman Neutral → Buy $45 → $72
Mar-06-20Initiated Citigroup Buy $69
Apr-14-21 05:05PM  
10:00AM  
Apr-13-21 06:50PM  
Apr-12-21 08:30AM  
Apr-09-21 07:00PM  
10:45AM  
Apr-08-21 04:20PM  
11:30AM  
Apr-07-21 04:34PM  
03:13PM  
01:30PM  
10:20AM  
Apr-06-21 07:48PM  
05:36PM  
03:39PM  
10:45AM  
09:05AM  
08:04AM  
04:55AM  
Apr-05-21 09:00PM  
04:11PM  
03:30PM  
11:32AM  
10:30AM  
07:43AM  
07:22AM  
06:30AM  
Mar-30-21 01:23PM  
Mar-29-21 12:07PM  
Mar-26-21 11:31AM  
Mar-24-21 02:34PM  
09:00AM  
07:28AM  
Mar-23-21 01:53PM  
Mar-15-21 05:14PM  
Mar-14-21 08:24PM  
Mar-12-21 01:15PM  
06:05AM  
Mar-10-21 04:02PM  
03:14PM  
12:34PM  
12:00PM  
02:50AM  
Mar-09-21 10:39PM  
07:41PM  
04:19PM  
12:00PM  
10:28AM  
09:20AM  
09:11AM  
08:37AM  
08:17AM  
Mar-08-21 07:16PM  
04:05PM  
Feb-25-21 09:17AM  
Feb-24-21 04:46PM  
04:05PM  
02:30PM  
Feb-23-21 10:11AM  
Feb-22-21 11:10PM  
Feb-19-21 09:00AM  
Feb-18-21 09:00AM  
Feb-10-21 09:00AM  
Jan-27-21 04:05PM  
Jan-11-21 01:31PM  
Dec-22-20 09:00AM  
Dec-15-20 02:34PM  
Dec-04-20 11:31AM  
Nov-24-20 11:21PM  
Nov-11-20 03:15AM  
Nov-10-20 09:00AM  
Nov-05-20 12:45PM  
06:07AM  
Nov-04-20 05:55PM  
04:05PM  
02:30PM  
Oct-28-20 12:32PM  
Oct-26-20 10:02PM  
09:00AM  
Oct-21-20 04:05PM  
Oct-14-20 04:05PM  
Oct-01-20 09:00AM  
Sep-07-20 05:15PM  
Sep-05-20 08:47AM  
Sep-04-20 11:31AM  
Sep-02-20 09:00AM  
Aug-31-20 09:00AM  
Aug-26-20 10:44PM  
01:01PM  
Aug-25-20 09:35AM  
09:00AM  
Aug-24-20 07:08AM  
Aug-23-20 11:33AM  
Aug-20-20 09:51AM  
Aug-12-20 09:00AM  
Aug-06-20 01:19PM  
Aug-05-20 06:25PM  
04:05PM  
Jul-31-20 08:00PM  
Jul-30-20 03:37PM  
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIM AUSTIN D.EVP & General CounselFeb 04Sale50.612,107106,6359,911Feb 08 09:00 PM
Stankovic Srdjan R.PresidentFeb 04Sale50.618,429426,59231,049Feb 08 09:00 PM
DAVIS STEPHENCEOFeb 04Sale50.6114,195718,40928,900Feb 08 09:00 PM
Ridloff ElenaEVP and CFOFeb 04Sale50.612,051103,8018,340Feb 08 09:00 PM
Stankovic Srdjan R.PresidentJan 12Option Exercise18.1270012,68420,947Jan 14 07:03 PM
Stankovic Srdjan R.PresidentJan 12Sale55.0170038,50720,247Jan 14 07:03 PM
Stankovic Srdjan R.PresidentJan 08Option Exercise27.4429,733815,98849,980Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 08Sale55.2229,7331,641,83220,247Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 07Option Exercise35.8061,6192,205,96081,866Jan 08 07:28 PM
Stankovic Srdjan R.PresidentJan 07Sale55.1261,6193,396,18720,247Jan 08 07:28 PM
YANG MICHAEL J.EVP and CCOJan 06Sale53.341,12059,7418,059Jan 08 07:31 PM
KIM AUSTIN D.EVP & General CounselJan 06Sale53.3467836,1655,518Jan 08 07:30 PM
Ridloff ElenaEVP and CFOJan 06Sale53.341,01654,1933,901Jan 08 07:29 PM
Stankovic Srdjan R.PresidentJan 06Sale53.341,72592,01220,247Jan 08 07:28 PM
DAVIS STEPHENCEOJan 06Sale53.343,484185,83724,482Jan 08 07:28 PM
Stankovic Srdjan R.PresidentNov 20Sale53.502,728145,94816,528Nov 20 09:29 PM
KIM AUSTIN D.EVP & General CounselOct 27Option Exercise17.588,750153,82512,601Oct 29 04:12 PM
KIM AUSTIN D.EVP & General CounselOct 27Sale45.108,750394,6363,851Oct 29 04:12 PM
YANG MICHAEL J.EVP and CCOOct 16Sale42.561,24753,0726,457Oct 19 05:27 PM
Stankovic Srdjan R.PresidentOct 16Sale42.561,29755,20013,006Oct 19 05:26 PM
DAVIS STEPHENCEOOct 16Sale42.562,960125,97814,786Oct 19 05:25 PM
YANG MICHAEL J.EVP and CCOJul 07Option Exercise23.0027,250626,77032,454Jul 09 06:26 PM
YANG MICHAEL J.EVP and CCOJul 07Sale56.2527,2501,532,7865,204Jul 09 06:26 PM
Stankovic Srdjan R.PresidentJun 19Option Exercise18.1216,452298,11027,786Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 19Sale50.1216,452824,51511,334Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Option Exercise18.8165,8431,238,69777,177Jun 19 06:55 PM
Stankovic Srdjan R.PresidentJun 18Sale50.0165,8433,292,72911,334Jun 19 06:55 PM
DAVIS STEPHENCEOMay 14Option Exercise19.6588,5421,739,850100,351May 15 07:11 PM
DAVIS STEPHENCEOMay 14Sale45.6288,5424,039,10511,809May 15 07:11 PM
DAVIS STEPHENCEOMay 13Option Exercise19.65111,4582,190,150123,267May 15 07:11 PM
DAVIS STEPHENCEOMay 13Sale46.35111,4585,165,58711,809May 15 07:11 PM
Daly James MDirectorMay 11Option Exercise26.3926,250692,70026,250May 13 06:00 PM
Daly James MDirectorMay 11Sale51.1326,2501,342,1780May 13 06:00 PM
Stankovic Srdjan R.PresidentApr 30Sale49.214,308211,99711,334May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 30Sale49.221,05051,6812,195May 01 06:00 PM
DAVIS STEPHENCEOApr 30Sale49.216,770333,15211,809May 01 06:00 PM
YANG MICHAEL J.EVP and CCOApr 30Sale49.211,50173,8645,204May 01 06:00 PM
KIM AUSTIN D.EVP & General CounselApr 30Sale49.221,07252,7642,441May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Option Exercise25.1210,000251,20010,000May 01 06:00 PM
Ridloff ElenaEVP and CFOApr 29Sale50.7410,000507,3530May 01 06:00 PM
Stankovic Srdjan R.PresidentApr 23Option Exercise20.6718,949391,70424,976Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 23Sale50.0718,949948,7296,027Apr 24 06:00 PM
Stankovic Srdjan R.PresidentApr 22Option Exercise19.7754,0191,067,95660,046Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 22Sale50.0254,0192,701,9066,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Option Exercise19.65100,0001,965,000106,027Apr 22 06:30 PM
Stankovic Srdjan R.PresidentApr 20Sale50.15100,0005,015,4506,027Apr 22 06:30 PM